Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.54
-0.20 (-2.58%)
At close: Oct 29, 2025, 4:00 PM EDT
7.54
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
Gyre Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Gyre Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $17, which forecasts a 125.46% increase in the stock price over the next year. The lowest target is $16 and the highest is $18.
Price Target: $17 (+125.46%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Gyre Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 |
|---|---|---|
| Strong Buy | 1 | 2 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +112.20% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +138.73% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
121.89M
from 105.76M
Increased by 15.25%
Revenue Next Year
162.28M
from 121.89M
Increased by 33.14%
EPS This Year
0.11
from 0.05
Increased by 119.22%
EPS Next Year
0.19
from 0.11
Increased by 80.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 128.3M | 249.9M | |
| Avg | 121.9M | 162.3M | |
| Low | 114.0M | 111.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 21.3% | 105.0% | |
| Avg | 15.3% | 33.1% | |
| Low | 7.8% | -8.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.18 | 0.54 | |
| Avg | 0.11 | 0.19 | |
| Low | 0.05 | 0.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 271.3% | 408.1% | |
| Avg | 119.2% | 80.7% | |
| Low | 1.9% | -90.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.